Both in Pharmaceuticals
Alzamend Neuro vs Exicure
Over the past year ALZN returned −52.1% and XCUR returned −75.2%; their daily moves had a correlation of 0.00.
ALZN −52.1% XCUR −75.2%Growth of $1, one year, split-adjusted
| Metric | ALZN | XCUR |
|---|---|---|
| Price | $1.12 | $1.13 |
| Market cap | $5.4M | $7.4M |
| Today | −10.40% | +11.88% |
| 1 month | −42.3% | −8.9% |
| 6 months | −0.9% | −69.0% |
| Year to date | −38.5% | −79.2% |
| 1 year | −53.3% | −75.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.6M | $1.7M |
| Dividend yield | — | — |
| Volatility (60d) | 78.4% | 87.1% |
| Short % of float | 3.3% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).